ArticleCancer research communications2025

High-Throughput Drug Screening of Clear Cell Ovarian Cancer Organoids Reveals Vulnerability to Proteasome Inhibitors and Dinaciclib and Identifies AGR2 as a Therapeutic Target.

Takuma Yoshimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.